Found: 14
Select item for more details and to access through your institution.
The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 978, doi. 10.1111/bjh.17062
- By:
- Publication type:
- Article
The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. E119, doi. 10.1002/ajh.26886
- By:
- Publication type:
- Article
How to improve RCHOP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of 21 randomized controlled trials.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 5, p. 1623, doi. 10.1007/s00277-023-05551-5
- By:
- Publication type:
- Article
Blood and platelet transfusion from a donor with presymptomatic Covid-19.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966121
- By:
- Publication type:
- Article
Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunoporosis: A New Role for Invariant Natural Killer T (NKT) Cells Through Overexpression of Nuclear Factor-κB Ligand (RANKL).
- Published in:
- Medical Science Monitor, 2019, v. 25, p. 2151, doi. 10.12659/MSM.912119
- By:
- Publication type:
- Article
Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00844-4
- By:
- Publication type:
- Article
Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 541, doi. 10.1002/hon.2756
- By:
- Publication type:
- Article
Natural History of Chronic Hepatitis B Virus Infection in Children of Different Ethnic Origins: A Cohort Study with Up to 12 Years' Follow-up in Northern Greece.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2007, v. 44, n. 1, p. 84, doi. 10.1097/01.mpg.0000243438.47334.07
- By:
- Publication type:
- Article
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort study.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.30
- By:
- Publication type:
- Article
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression.
- Published in:
- Genome Medicine, 2019, v. 11, n. 1, p. 1, doi. 10.1186/s13073-019-0707-x
- By:
- Publication type:
- Article